Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in …
K Liu, X He, J Huang, S Yu, M Cui, M Gao, L Liu… - Clinical …, 2023 - Springer
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterized by
chronic low-grade inflammation. Previous studies have demonstrated that the gut …
chronic low-grade inflammation. Previous studies have demonstrated that the gut …
[HTML][HTML] Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis-radix rehmanniae drug pair
X Li, I Ullah, C Hou, Y Liu, K Xiao - Medicine, 2023 - journals.lww.com
This study aimed to investigate the angelica sinensis-radix rehmanniae (AR) role in
polycystic ovary syndrome (PCOS), employing network pharmacology and molecular …
polycystic ovary syndrome (PCOS), employing network pharmacology and molecular …
Relationship between Polycystic Ovary Syndrome and Metabolic Syndrome
HIS Cerón - The Journal of Reproduction, 2023 - thejournalofreproduction.com
Polycystic ovary syndrome (PCOS) is a heterogeneous, complex, and widely misunderstood
endocrine disorder that affects intermediate metabolism, the cardiovascular and …
endocrine disorder that affects intermediate metabolism, the cardiovascular and …
Interleukin-1 increases SERPINE1 expression in human granulosa-lutein cell via P50/P52 signaling pathways
Y Xiang, S Liu, S Wan, Q Chen, Y Song, G Feng… - Molecular and Cellular …, 2024 - Elsevier
It has been reported that immune factors are associated with the occurrence of polycystic
ovary syndrome (PCOS). Interleukin-1 (IL-1) is a member of the interleukin family that widely …
ovary syndrome (PCOS). Interleukin-1 (IL-1) is a member of the interleukin family that widely …